2021-01-05,Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
2020-12-30,Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
2020-12-15,"Morphic Holding's (MORF) Shares March Higher, Can It Continue?"
2020-12-09,Is MORF A Good Stock To Buy Now?
2020-12-04,Morphic Therapeutic Announces Appointment of Dr. Martin W. Edwards as Member of its Board of Directors
2020-11-17,Morphic Therapeutic to Present at the Jefferies Virtual London Healthcare Conference
2020-11-11,"Results: Morphic Holding, Inc. Confounded Analyst Expectations With A Surprise Profit"
2020-11-09,Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
2020-11-05,We Think Morphic Holding (NASDAQ:MORF) Can Easily Afford To Drive Business Growth
2020-10-12,Morphic Announces Presentation of New Data Supporting Development of MORF-057 at UEG Week Virtual 2020
2020-09-28,A Look Into Healthcare Sector Value Stocks
2020-09-23,Morphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057
2020-09-21,Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit
2020-09-03,Morphic Announces Participation in Upcoming Investor Conferences
2020-08-25,"The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout"
2020-08-25,"Morphic Announces that AbbVie Exercises License Option to v6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases"
2020-08-10,"Morphic Holding, Inc. (MORF) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-10,Morphic Announces Corporate Highlights and Second Quarter 2020 Financial Results
2020-08-07,Morphic Holding's (NASDAQ:MORF) Stock Price Has Reduced13% In The Past Year
2020-08-03,"Morphic Holding, Inc. (MORF) May Report Negative Earnings: Know the Trend Ahead of Q2 Release"
2020-06-29,Morphic Therapeutic Presents Positive Preclinical Data Supporting Development of MORF-057 in Inflammatory Bowel Disease at Digestive Disease Week 2020
2020-06-18,Morphic to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
2020-06-15,"Hedge Funds Nibbling On Morphic Holding, Inc. (MORF)"
2020-05-27,Morphic to Present at the Jefferies Virtual Healthcare Conference
2020-05-06,Morphic Announces Corporate Highlights and First Quarter 2020 Financial Results
2020-04-29,Morphic Therapeutic to Present at the BofA Securities 2020 Health Care Conference
2020-04-07,"Morphic Announces Appointment of Marc Schegerin, M.D., as Chief Financial Officer and Chief Operating Officer"
2020-03-17,"Morphic Announces Appointment of Peter G. Linde, M.D., as Chief Medical Officer"
2020-02-28,Morphic Therapeutic to Present at the 40th Annual Cowen Health Care Conference
2020-02-27,Morphic Announces Corporate Highlights and Financial Results for the Full Year 2019
2020-02-14,Morphic Presents Positive Preclinical Data Supporting MORF-057 as an Oral Inhibitor of the 47 Integrin and Potential Treatment for Inflammatory Bowel Disease
2020-01-08,Morphic to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-11-30,"Hedge Funds Are Dumping Morphic Holding, Inc. (MORF)"
2019-11-18,Morphic to Present at the Jefferies 2019 London Healthcare Conference
2019-11-12,Morphic Announces Corporate Highlights and Third Quarter 2019 Financial Results
2019-10-30,"Hedge Funds Have Never Been This Bullish On Morphic Holding, Inc. (MORF)"
2019-08-30,Morphic to Present at the Wells Fargo Securities 2019 Healthcare Conference
2019-08-12,Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
2019-07-17,"Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer"
2019-07-01,Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2019-06-26,Morphic Announces Pricing of Upsized Initial Public Offering
